Stilla Inc. opened
Invention of the technology at Ecole Polytechnique France
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica™ System.
Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity in all Life Sciences areas: research, therapeutics, and all the “omics”.
Stilla advises and supports its customers worldwide through its dynamic and multidisciplinary R&D team, with expertise spanning microfluidics, chemistry, molecular biology and computer science. Stilla is continuously looking to innovate with the Naica™ System and is working on the 2nd generation of the platform to further increase the multiplexing capability and throughput of the system.
China & South East Asia